| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.52B | 162.03B | 131.89B | 128.00B | 111.80B | 116.28B |
| Gross Profit | 123.97B | 143.14B | 120.72B | 120.69B | 107.55B | 108.46B |
| EBITDA | 30.66B | 43.17B | 34.53B | 31.53B | 30.49B | 30.46B |
| Net Income | 20.62B | 27.38B | 20.84B | 19.32B | 18.63B | 17.19B |
Balance Sheet | ||||||
| Total Assets | 7.72T | 7.53T | 7.60T | 7.54T | 7.19T | 8.38T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.11T | 1.08T | 973.95B | 752.03B | 2.14T |
| Total Debt | 741.71B | 553.97B | 706.64B | 687.58B | 651.20B | 1.63T |
| Total Liabilities | 7.29T | 7.05T | 7.17T | 7.08T | 6.80T | 7.97T |
| Stockholders Equity | 430.79B | 468.46B | 419.13B | 446.67B | 388.72B | 398.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.26B | 0.00 | 0.00 | -1.37T | 0.00 |
| Operating Cash Flow | 0.00 | 20.38B | 0.00 | 0.00 | -1.37T | 0.00 |
| Investing Cash Flow | 0.00 | 152.21B | 107.83B | 70.66B | -8.18B | 82.70B |
| Financing Cash Flow | 0.00 | -148.13B | 97.55B | 115.21B | -5.92B | 131.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥483.33B | 17.26 | 3.95% | 2.19% | 16.41% | 51.17% | |
71 Outperform | ¥374.76B | 13.81 | ― | 2.94% | 14.34% | 213.31% | |
69 Neutral | ¥333.25B | -0.79 | ― | 2.14% | 19.10% | 141.03% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥460.26B | 21.66 | ― | 1.50% | 18.76% | 15.43% | |
64 Neutral | ¥348.83B | 8.58 | ― | 1.95% | 17.98% | 32.53% | |
55 Neutral | ¥234.47B | 18.32 | ― | 2.38% | 33.44% | 57.44% |